<!DOCTYPE HTML PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<HTML lang="pt-BR">
<HEAD>
<META http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<link href="images/v2/fav_ico_lattes.ico" rel="Shortcut Icon">
<meta content="Sistema de Curr&iacute;culos Lattes 2.0 (CNPq)" http-equiv="generator">
<meta content="curr&iacute;culo,curriculo,curriculum,cv,vitae,lattes,produ&ccedil;&atilde;o,producao,cient&iacute;fica,cientifica,Brasil" http-equiv="keywords">
<TITLE>Curr&iacute;culo do Sistema de Curr&iacute;culos Lattes (Gilberto De Lima Lopes Junior)</TITLE>
<link type="text/css" rel="stylesheet" href="css/import.css">
<link type="text/css" href="css/tablet-mobile.css" rel="stylesheet">
<link type="text/css" rel="stylesheet" href="css/jquery.megamenu.css">
<link type="text/css" rel="stylesheet" href="css/style_curiculo.css">
<link type="text/css" rel="stylesheet" href="css/v2/espelho.css">
<link type="text/css" rel="stylesheet" href="css/impressao.css">
<script type="text/javascript" src="js/v2/jquery.min.js"></script><script src="js/jquery.cookie.js" type="text/javascript"></script><script src="js/acessibilidade.js" type="text/javascript"></script><script type="text/javascript" src="js/v2/tooltip-position.js"></script><script type="text/javascript" src="js/v2/jquery.tipsy.js"></script><script type="text/javascript" src="js/v2/jquery.megamenu.js"></script><script type="text/javascript" src="js/v2/byOrder.js"></script><script type="text/javascript" src="js/v2/font-size.js"></script><script type="text/javascript" src="js/v2/cv_citacoes.js"></script><script type="text/javascript" src="js/v2/hint_ajax.js"></script><script type="text/javascript" src="js/v2/menuFlowScroll.js"></script><script type="text/javascript" src="js/v2/videoUtils.js"></script><script type="text/javascript">
			
			var menu = {
				iniciar: function(id) {
					jkmegamenu.definemenu("ancora-menu-" + id, "menu-" + id, "focus");
				}
			};
			
			function abreLinkHistoricoPublicacoes(codigo,nome){
            	var j = window.open("historicoAtualizacao.jsp?id="+codigo+"&nome="+nome+"&fromBusca=1", "historico","resizable=no,menubar=no,toolbar=no,status=yes,scrollbars=yes,width=550px,height=470px,left=0,top=0");
            	if(j){
            		j.focus();
            	} else {
            		alert('Por favor, desabilite o bloqueador de popups');
            	}
			}
			
			var autores = {
				exibir: function() {
					$(this).hide().parent().find(".autores-et-al").show();
				},
				ocultar: function() {
					$(this).parent().hide().parent().find(".autores-et-al-plus").show();
				}
			};
				
			$(document).ready(function(){
			
				$(".ajaxJCR").ajaxJCR();
				
				$(".ajaxCAPES").ajaxCAPES();
				
				$(".ajaxINPI").ajaxINPI();
				
				$("div.citacoes").verificarCitacoes();
				
				$(".tooltip").tipsy({gravity: 's'});
				
				$(".autores-et-al-plus").click(autores.exibir);
				
				$(".autores-et-al-minus").click(autores.ocultar);
        			
      		});			  
      		
      		                                
		
	</script><script type="text/javascript">
					
					  var _gaq = _gaq || [];
					  _gaq.push(['_setAccount', 'UA-35652740-1']);
					  _gaq.push(['_trackPageview']);
					
					  (function() {
					    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
					    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
					    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
					  })();
					
					</script>
</HEAD>
<BODY>
<div class="page min-width">
<div class="header">
<div class="header-content max-width">
<div class="identity center">
<div class="combo">
<h1 class="escondido"> Curr&iacute;culo Lattes - Busca Textual - Visualiza&ccedil;&atilde;o do Curr&iacute;culo </h1>
<a href="http://lattes.cnpq.br/" title="Curr&iacute;culo Lattes" target="_blank"><img title="Curr&iacute;culo Lattes" alt="Curr&iacute;culo Lattes" src="images/titulo-sistema.png"></a>
</div>
<div class="menu-header">
<span class="tituloFlow"></span><span class="linksFlow"><a href="http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4794811U3&amp;idiomaExibicao=2" class="btn-br">English</a><a title="Imprimir curr&iacute;culo" class="bt-menu-header titBottom  icons-top icons-top-print" href="javascript:window.print()"></a><a title="Aumentar a fonte" class="bt-menu-header titBottom fontMais icons-top icons-top-fontMais" href="javascript:void(0)"></a><a title="Fonte padr&atilde;o" class="bt-menu-header titBottom fontMenos icons-top icons-top-fontMenos" href="javascript:void(0)"></a><a title="Alto contraste" class="bt-menu-header titBottom contraste icons-top icons-top-contraste-en" href="javascript:void(0)"></a><a href="download.do?metodo=apresentar&amp;idcnpq=2260229603109116" target="_blank" class="bt-menu-header titBottom fontMenos icons-top icons-top-xml" title="Baixar Currículo em XML" /><a title="Ajuda" class="bt-menu-header titBottom icons-top icons-top-help" target="_blank" href="http://ajuda.cnpq.br/index.php"></a></span>
</div>
<div class="logo">
<a target="_blank" href="http://cnpq.br/">
<h2>CNPq - Conselho Nacional de Desenvolvimento Cient&iacute;fico e Tecnol&oacute;gico</h2>
</a>
</div>
</div>
</div>
</div>
<div class="navigation-wrapper">
<div class="center navigation-wrapper-line">
<div class="menuPrincipal">
<div class="menuCtl menuAcesso">
<div class="menucent"><script type='text/javascript'>menu.iniciar("dados-gerais");</script>
		
		
		<a id="ancora-menu-dados-gerais" href="javascript:void(0)" class="acessibilidade"><span></span>Dados gerais</a>
		
	
		
		
		<div id="menu-dados-gerais" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#Identificacao">Identificação</a></li>
		
	
		
		
		<li><a href="#Endereco">Endereço</a></li>
		
	
		
		
		<li><a href="#Idiomas">Idiomas</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("formacao");</script>
		
		
		<a id="ancora-menu-formacao" href="javascript:void(0)" class="acessibilidade separador"><span></span>Formação</a>
		
	
		
		
		<div id="menu-formacao" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#FormacaoAcademicaTitulacao">Formação acadêmica/titulação</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("atuacao");</script>
		
		
		<a id="ancora-menu-atuacao" href="javascript:void(0)" class="acessibilidade separador"><span></span>Atuação</a>
		
	
		
		
		<div id="menu-atuacao" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#AreasAtuacao">Áreas de atuação</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("producoes");</script>
		
		
		<a id="ancora-menu-producoes" href="#ProducoesCientificas" class="acessibilidade separador"><span></span>Produções</a>
		
	
		
		
		<div id="menu-producoes" class="megamenu">
		
		<div class='column'><div class='subtitMenu'><a href='#ProducaoBibliografica'>Produção Bibliográfica</a></div><h3></h3><ul>
		
		
		<li><a href="#ArtigosCompletos">Artigos completos publicados em periódicos</a></li>
		
	
		
		
		<li><a href="#ArtigosAceitos">Artigos aceitos para publicação</a></li>
		
	
		
		
		<li><a href="#LivrosCapitulos">Livros e capítulos</a></li>
		
	
		
		
		<li><a href="#TextosJornaisRevistas">Textos em jornais ou revistas (magazine)</a></li>
		
	
		
		
		<li><a href="#TrabalhosPublicadosAnaisCongresso">Trabalhos publicados em anais de congressos</a></li>
		
	
		
		
		<li><a href="#ApresentacaoTrabalho">Apresentações de trabalho</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesBibliograficas">Partitura musical</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesBibliograficas">Tradução</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesBibliograficas">Prefácio, pósfacio</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesBibliograficas">Outras produções bibliográficas</a></li>
		
	</ul></div><div class='column'><div class='subtitMenu'><a href='#ProducaoTecnica'>Produção Técnica</a></div><h3></h3><ul>
		
		
		<li><a href="#AssessoriaConsultoria">Assessoria e consultoria</a></li>
		
	
		
		
		<li><a href="#SoftwareSemPatente">Programas de computador sem registro</a></li>
		
	
		
		
		<li><a href="#ProdutosTecnologicos">Produtos tecnológicos</a></li>
		
	
		
		
		<li><a href="#ProcessosTecnicas">Processos e técnicas</a></li>
		
	
		
		
		<li><a href="#TrabalhosTecnicos">Trabalhos técnicos</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Cartas, mapas ou similares</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Curso de curta duração ministrado</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Desenvolvimento de material didático ou instrucional</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Editoração</a></li>
		
	
		
		
		<li><a href="#ManutencaoObraArtistica">Manutenção de obra artística</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Maquete</a></li>
		
	
		
		
		<li><a href="#EntrevistasMesasRedondas">Entrevistas, mesas redondas, programas e comentários na mídia</a></li>
		
	
		
		
		<li><a href="#DemaisProducaoTecnica">Relatório de pesquisa</a></li>
		
	
		
		
		<li><a href="#RedesSociais">Redes sociais, websites e blogs</a></li>
		
	
		
		
		<li><a href="#DemaisProducoesTecnicas">Outras produções técnicas</a></li>
		
	</ul></div><div class='column'><div class='subtitMenu'><a href='#ProducaoArtisticaCultural'>Produção Artística/Cultural</a></div><h3></h3><ul>
		
		
		<li><a href="#ArtesCenicas">Artes cênicas</a></li>
		
	
		
		
		<li><a href="#Musica">Música</a></li>
		
	
		
		
		<li><a href="#ArtesVisuais">Artes visuais</a></li>
		
	
		
		
		<li><a href="#OutrasProducoesArtisticas">Outras produções artísticas/culturais</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("eventos");</script>
		
		
		<a id="ancora-menu-eventos" href="#Eventos" class="acessibilidade separador"><span></span>Eventos</a>
		
	
		
		
		<div id="menu-eventos" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="#ParticipacaoEventos">Participação em eventos, congressos, exposições e feiras</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	<script type='text/javascript'>menu.iniciar("informacoes-complementares");</script>
		
		
		<a id="ancora-menu-informacoes-complementares" href="javascript:void(0)" class="acessibilidade separador"><span></span>+</a>
		
	
		
		
		<div id="menu-informacoes-complementares" class="megamenu">
		
		<div class='column'><h3></h3><ul>
		
		
		<li><a href="visualizacv.do?metodo=apresentar&id=K4794811U3&tipo=completo&idiomaExibicao=1">Mostrar informações complementares</a></li>
		
	</ul></div>
		
		
		<div class="clear"></div></div>
		
	</div>
</div>
</div>
</div>
</div>
<div class="content-wrapper">
<div class="main-content max-width min-width center">
<div class="layout-cell layout-cell-12">
<div class="layout-cell-pad-main">
<img class="foto" src="http://servicosweb.cnpq.br/wspessoa/servletrecuperafoto?tipo=1&amp;id=K4794811U3"><div class="infpessoa">
<h2 class="nome">Gilberto De Lima Lopes Junior</h2>
<ul class="informacoes-autor">
<li>
<span class="img_link icone-informacao-autor"></span>Endere&ccedil;o para acessar este CV: http://lattes.cnpq.br/2260229603109116</li>
<li>
<span class="img_cert icone-informacao-autor"></span>&Uacute;ltima atualiza&ccedil;&atilde;o do curr&iacute;culo em 01/09/2013</li>
</ul>
</div><br class="clear" /><div class="title-wrapper">
<h1 class="ui-hidden"></h1>
<hr class="separator">
<p class="resumo">Possui gradua&ccedil;&atilde;o  em Medicina pela Universidade Federal do Rio Grande do Sul(1997), especializa&ccedil;&atilde;o  em MBA pela University of Bradford(2009), residencia-medicapela Hospital de Cl&iacute;nicas de Porto Alegre(1999), residencia-medicapela University of Miami Hospital(2002) e residencia-medicapela University of Miami Hospital(2006). Tem experi&ecirc;ncia na &aacute;rea de Medicina, com &ecirc;nfase em Cl&iacute;nica M&eacute;dica. <span style="font-weight: bold" class="texto"> (Texto gerado automaticamente pela aplica&ccedil;&atilde;o CVLattes)</span>
</p>
</div><br class="clear" /><div class="title-wrapper">
<a name="Identificacao">
<h1>Identifica&ccedil;&atilde;o</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Nome</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Gilberto De Lima Lopes Junior<img src='/buscatextual/images/icon-rfb.png' class='alinhamento-texto-img'  title='Dados cadastrais validados junto a Receita Federal do Brasil' /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Nome em citações bibliográficas</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">LOPES JUNIOR, G. L.;Lopes, G.;Lopes G;Gilberto Lopes;DE LIMA LOPES, G.;LOPES, GILBERTO;DE LIMA LOPES, GILBERTO;LOPES JR., GILBERTO DE LIMA;DE LIMA LOPES JR, GILBERTO;LIMA LOPES, GILBERTO;LIMA JOPES JR, GILBERTO DE;LOPES, GILBERTO DE LIMA</div>
</div>
</div>
</div><br class="clear" /><div class="title-wrapper">
<a name="Endereco">
<h1>Endere&ccedil;o</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Endereço Profissional</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Johns Hopkins University. <br class="clear" />11 Jalan Tan Tock Seng<br class="clear" />Level 1<br class="clear" />308433 - Singapore,  - Cingapura<br class="clear" />Telefone: (65) 9621816</div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="FormacaoAcademicaTitulacao">
<h1>Forma&ccedil;&atilde;o acad&ecirc;mica/titula&ccedil;&atilde;o</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2003 - 2006</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Especialização - Residência médica<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />University of Miami Hospital.
		
	Residência médica em: Hematology/Oncology Fellowship<br class="clear" />Número do registro: . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1999 - 2002</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Especialização - Residência médica<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />University of Miami Hospital.
		
	Residência médica em: Medicina Interna<br class="clear" />Número do registro: . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1998 - 1999</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Especialização - Residência médica<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />Hospital de Clínicas de Porto Alegre.
		
	Residência médica em: Medicina Interna<br class="clear" />Número do registro: . </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2009 - 2009</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Especialização em MBA<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />University of Bradford, BRADFORD, Inglaterra.
		
	<br class="clear" />Título: An assessment of the societal costs and benefits of adjuvant trastuzumab in the treatment of early breast cancer in Singapore. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1991 - 1997</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Graduação em Medicina<span class="ajaxCAPES" data-param="&codigoCurso=&nivelCurso="></span>. <br class="clear" />Universidade Federal do Rio Grande do Sul, UFRGS, Brasil.
		
	</div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<div class="layout-cell layout-cell-12 data-cell"></div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="AreasAtuacao">
<h1>&Aacute;reas de atua&ccedil;&atilde;o</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Grande área: Ciências da Saúde / Área: Medicina / Subárea: Clínica Médica. <br class="clear" /></div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Grande área: Ciências da Saúde / Área: Medicina / Subárea: Oncologia. <br class="clear" /></div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="Idiomas">
<h1>Idiomas</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Inglês</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Compreende Bem, Fala Bem, Lê Bem, Escreve Bem. </div>
</div>
<div class="layout-cell layout-cell-3 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>Espanhol</b>
</div>
</div>
<div class="layout-cell layout-cell-9">
<div class="layout-cell-pad-5">Compreende Bem, Fala Bem, Lê Bem, Escreve Bem. </div>
</div>
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="ProducoesCientificas">
<h1>Produ&ccedil;&otilde;es</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<a name="ProducaoBibliografica"></a><br class="clear" /><div class="inst_back">
<b>Produção bibliográfica</b>
</div>
<a name="Citacoes"></a>
<div id="artigos-completos">
<div class="cita-artigos">
<b><a name="ArtigosCompletos"></a>Artigos completos publicados em periódicos</b>
</div><br class="clear" /><div class="layout-cell-6">
<div class="sub_tit_form">
<label for="combo-ordenacao-citacao">Ordenar por</label><select class="input-text input-login-select" id="combo-ordenacao-citacao"><option value="1"> Ordem Cronol&oacute;gica </option><option value="2"> N&uacute;mero de cita&ccedil;&otilde;es Web of science </option><option value="3"> N&uacute;mero de cita&ccedil;&otilde;es Scopus </option><option value="4"> Numero de cita&ccedil;&otilde;es Scielo </option><option value="5"> Primeiro autor </option><option value="6"> Impacto JCR </option><option value="7"> Ordem de Import&acirc;ncia </option></select>
</div>
</div>
<script type="text/javascript">
			
				var ordenacao = {
					engine: {
						textual: function(seletor) {
						
							$("#artigos-completos").find(".artigo-completo").sortElements(function(a, b){
								var v1 = $(a).find(seletor).text();
								var v2 = $(b).find(seletor).text();
								return (v1 > v2) ? 1 : -1;
							});
						},
						numerico: function(seletor) {
						
							$("#artigos-completos").find(".artigo-completo").sortElements(function(a, b){
								var v1 = parseInt($(a).find(seletor).text(), 10);
								var v2 = parseInt($(b).find(seletor).text(), 10);
								if (isNaN(v1)) v1 = 0;
								if (isNaN(v1)) v2 = 0;
								return (v1 < v2) ? 1 : -1;
							});
						},
						numerico_crescente: function(seletor) {
						
							$("#artigos-completos").find(".artigo-completo").sortElements(function(a, b){
								var v1 = parseInt($(a).find(seletor).text(), 10);
								var v2 = parseInt($(b).find(seletor).text(), 10);
								if (isNaN(v1)) v1 = 0;
								if (isNaN(v1)) v2 = 0;
								return (v1 > v2) ? 1 : -1;
							});
						}
					},
					change: function(e) {
					
						var combo = $(e.target),
							valor = combo.val();
							
						if (valor == 1) ordenacao.engine.numerico("span[data-tipo-ordenacao='ano']");
						if (valor == 2) ordenacao.engine.numerico("span[data-tipo-ordenacao='1']");
						if (valor == 3) ordenacao.engine.numerico("span[data-tipo-ordenacao='3']");						
						if (valor == 4) ordenacao.engine.numerico("span[data-tipo-ordenacao='2']");
						if (valor == 5) ordenacao.engine.textual("span[data-tipo-ordenacao='autor']");
						if (valor == 6) ordenacao.engine.numerico("span[data-tipo-ordenacao='jcr']");
						if (valor == 7) ordenacao.engine.numerico_crescente("span[data-tipo-ordenacao='importancia']");
							
					}
				};
			
				$("#combo-ordenacao-citacao").bind("change", ordenacao.change);
			
			</script>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>HOSEIN, PETER J.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1097/COC.0b013e3182436e8c" target="_blank"></a>HOSEIN, PETER J. ; <b>DE LIMA LOPES, GILBERTO</b> ; PASTORINI, VITOR H. ; GOMEZ, CHRISTINA ; MACINTYRE, JESSICA ; ZAYAS, GLORIA ; REIS, ISILDINHA ; MONTERO, ALBERTO J. ; MERCHAN, JAIME R. ; ROCHA LIMA, CAIO M. . A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer. American Journal of Clinical Oncology<sup><img id='02773732_1' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='02773732' /></sup>, v. 36, p. 151-156, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1097/COC.0b013e3182436e8c&issn=02773732&volume=36&issue=&paginaInicial=151&titulo=A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer&sequencial=1&nomePeriodico=American Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s10549-012-2326-8" target="_blank"></a><b>LOPES, GILBERTO</b>; GLÜCK, STEFAN ; AVANCHA, KIRAN ; MONTERO, ALBERTO J. . A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer. Breast Cancer Research and Treatment<sup><img id='01676806_2' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01676806' /></sup>, v. 137, p. 187-193, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s10549-012-2326-8&issn=01676806&volume=137&issue=&paginaInicial=187&titulo=A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer&sequencial=2&nomePeriodico=Breast Cancer Research and Treatment" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE LIMA LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1111/tbj.12092" target="_blank"></a><b>DE LIMA LOPES, GILBERTO</b>; CHIEN, REBECCA ; HORNBERGER, JOHN . Cost-benefit of the 21-gene Breast Cancer Recurrence Score Assay for Patients in Singapore. The Breast Journal<sup><img id='1075122X_3' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='1075122X' /></sup>, v. 19, p. 220-221, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1111/tbj.12092&issn=1075122X&volume=19&issue=&paginaInicial=220&titulo=Cost-benefit of the 21-gene Breast Cancer Recurrence Score Assay for Patients in Singapore&sequencial=3&nomePeriodico=The Breast Journal" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SOON, SWEE-SUNG</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.7314/APJCP.2013.14.4.2159" target="_blank"></a>SOON, SWEE-SUNG ; LIM, HWEE-YONG ; <b>LOPES, GILBERTO</b> ; AHN, JEONGHOON ; HU, MIN ; IBRAHIM, HISHAMSHAH MOHD ; JHA, ANAND ; KO, BOR-SHENG ; LEE, PAK WAI ; MACDONELL, DIANA ; SIRACHAINAN, EKAPHOP ; WEE, HWEE-LIN . Roles of Cancer Registries in Enhancing Oncology Drug Access in the Asia-Pacific Region. Asian Pacific Journal of Cancer Prevention<sup><img id='15137368_4' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15137368' /></sup>, v. 14, p. 2159-2165, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.7314/APJCP.2013.14.4.2159&issn=15137368&volume=14&issue=&paginaInicial=2159&titulo=Roles of Cancer Registries in Enhancing Oncology Drug Access in the Asia-Pacific Region&sequencial=4&nomePeriodico=Asian Pacific Journal of Cancer Prevention" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>CRUZ, MARCELO R. S.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s11888-012-0148-z" target="_blank"></a>CRUZ, MARCELO R. S. ; <b>DE LIMA LOPES, GILBERTO</b> . Colon Cancer Liver Metastasis: Addition of Antiangiogenesis or EGFR Inhibitors to Chemotherapy. Current Colorectal Cancer Reports<sup><img id='15563790_5' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15563790' /></sup>, v. 9, p. 68-73, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s11888-012-0148-z&issn=15563790&volume=9&issue=&paginaInicial=68&titulo=Colon Cancer Liver Metastasis: Addition of Antiangiogenesis or EGFR Inhibitors to Chemotherapy&sequencial=5&nomePeriodico=Current Colorectal Cancer Reports" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>GOSS, PAUL E</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/s1470-2045(13)70048-2" target="_blank"></a>GOSS, PAUL E LEE, BRITTANY L BADOVINAC-CRNJEVIC, TANJA STRASSER-WEIPPL, KATHRIN CHAVARRI-GUERRA, YANIN LOUIS, JESSICA ST VILLARREAL-GARZA, CYNTHIA UNGER-SALDAÑA, KARLA FERREYRA, MAYRA DEBIASI, MÁRCIO LIEDKE, PEDRO ER TOUYA, DIEGO WERUTSKY, GUSTAVO HIGGINS, MICHAELA FAN, LEI VASCONCELOS, CLAUDIA CAZAP, EDUARDO VALLEJOS, CARLOS MOHAR, ALEJANDRO KNAUL, FELICIA ARREOLA, HECTOR BATURA, REKHA LUCIANI, SILVANA SULLIVAN, RICHARD FINKELSTEIN, DIANNE ,  <a title="Clique para visualizar todos os autores" class="tooltip autores-et-al-plus" href="javascript:void(0)">et al.<span></span></a><span class='autores-et-al'>SIMON, SERGIO BARRIOS, CARLOS KIGHTLINGER, REBECCA GELRUD, ANDRES BYCHKOVSKY, VLADIMIR <b>LOPES, GILBERTO</b> STEFANI, STEPHEN BLAYA, MARCELO SOUZA, FABIANO HAHN SANTOS, FRANKLIN SANTANA KAEMMERER, ALBERTO DE AZAMBUJA, EVANDRO ZORILLA, ANDRES FELIPE CARDONA MURILLO, RAUL JERONIMO, JOSE TSU, VIVIEN CARVALHO, ANDRE GIL, CARLOS FERREIRA STERNBERG, CINTHYA DUEÑAS-GONZALEZ, ALFONSO SGROI, DENNIS CUELLO, MAURICIO FRESCO, RODRIGO REIS, RUI MANUEL MASERA, GUISEPPE GABÚS, RAÚL RIBEIRO, RAUL KNUST, RENATA ISMAEL, GUSTAVO ROSENBLATT, EDUARDO ROTH, BERTA VILLA, LUISA SOLARES, ARGELIA LARA LEON, MARTA XIMENA TORRES-VIGIL, ISABEL COVARRUBIAS-GOMEZ, ALFREDO HERNÁNDEZ, ANDRÉS BERTOLINO, MARIELA SCHWARTSMANN, GILBERTO SANTILLANA, SERGIO ESTEVA, FRANCISCO FEIN, LUIS MANO, MAX GOMEZ, HENRY HURLBERT, MARC DURSTINE, ALESSANDRA AZENHA, GUSTAVO <a href="javascript:void(0)" title="Clique para ocultar os autores" class="tooltip autores-et-al-minus"></a></span> ; Planning cancer control in Latin America and the Caribbean. Lancet Oncology<sup><img id='14702045_6' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14702045' /></sup>, v. 14, p. 391-436, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/s1470-2045(13)70048-2&issn=14702045&volume=14&issue=&paginaInicial=391&titulo=Planning cancer control in Latin America and the Caribbean&sequencial=6&nomePeriodico=Lancet Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>LOPES, GILBERTO DE LIMA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1038/nrclinonc.2013.55" target="_blank"></a><b>LOPES, GILBERTO DE LIMA</b>; DE SOUZA, JONAS A. ; BARRIOS, CARLOS . Access to cancer medications in low- and middle-income countries. NAT REV CLIN ONCOL<sup><img id='17594774_7' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='17594774' /></sup>, v. 10, p. 314-322, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1038/nrclinonc.2013.55&issn=17594774&volume=10&issue=&paginaInicial=314&titulo=Access to cancer medications in low- and middle-income countries&sequencial=7&nomePeriodico=NAT REV CLIN ONCOL" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE SOUZA, JONAS A.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2013</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1097/CCO.0b013e32835ff422" target="_blank"></a>DE SOUZA, JONAS A. ; <b>LOPES, GILBERTO DE LIMA</b> ; COHEN, EZRA E.W. . Pharmacoeconomic issues in head and neck oncology. Current Opinion in Oncology<sup><img id='10408746_8' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10408746' /></sup>, v. 25, p. 1-217, 2013. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1097/CCO.0b013e32835ff422&issn=10408746&volume=25&issue=&paginaInicial=1&titulo=Pharmacoeconomic issues in head and neck oncology&sequencial=8&nomePeriodico=Current Opinion in Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MERCHAN, JAIME R.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1097/COC.0b013e31821862fb" target="_blank"></a>MERCHAN, JAIME R. ; FERRELL, ANNAPORNA ; MACINTYRE, JESSICA ; CIOMBOR, KRISTEN K. ; LEVI, JOE ; RIBEIRO, AFONSO ; SLEEMAN, DANNY ; FLORES, AUREA ; <b>LOPES, GILBERTO</b> ; ROCHA-LIMA, CAIO M. . Phase II Study of Gemcitabine, Oxaliplatin, and Cetuximab in Advanced Pancreatic Cancer. American Journal of Clinical Oncology<sup><img id='02773732_9' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='02773732' /></sup>, v. 35, p. 446-450, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1097/COC.0b013e31821862fb&issn=02773732&volume=35&issue=&paginaInicial=446&titulo=Phase II Study of Gemcitabine, Oxaliplatin, and Cetuximab in Advanced Pancreatic Cancer&sequencial=9&nomePeriodico=American Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE LIMA LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1002/cncr.26372" target="_blank"></a><b>DE LIMA LOPES, GILBERTO</b>; SEGEL, JOEL E. ; TAN, DANIEL S. W. ; DO, YOUNG K. ; MOK, TONY ; FINKELSTEIN, ERIC A. . Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung. Cancer (Print)<sup><img id='0008543X_10' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0008543X' /></sup>, v. 118, p. 1032-1039, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1002/cncr.26372&issn=0008543X&volume=118&issue=&paginaInicial=1032&titulo=Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung&sequencial=10&nomePeriodico=Cancer (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MONTERO, ALBERTO J.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s10549-011-1919-y" target="_blank"></a>MONTERO, ALBERTO J. ; AVANCHA, KIRAN ; GLÜCK, STEFAN ; <b>LOPES, GILBERTO</b> . A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer. Breast Cancer Research and Treatment<sup><img id='01676806_11' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01676806' /></sup>, v. 132, p. 747-751, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s10549-011-1919-y&issn=01676806&volume=132&issue=&paginaInicial=747&titulo=A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer&sequencial=11&nomePeriodico=Breast Cancer Research and Treatment" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>KU, GEOFFREY Y.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s00280-012-1898-7" target="_blank"></a>KU, GEOFFREY Y. ; HAALAND, BENJAMIN A. ; <b>LIMA LOPES, GILBERTO</b> . Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters. Cancer Chemotherapy and Pharmacology<sup><img id='03445704_12' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03445704' /></sup>, v. 70, p. 231-238, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s00280-012-1898-7&issn=03445704&volume=70&issue=&paginaInicial=231&titulo=Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters&sequencial=12&nomePeriodico=Cancer Chemotherapy and Pharmacology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>PARKER, JAYSON L.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s10549-012-2247-6" target="_blank"></a>PARKER, JAYSON L. ; LUSHINA, NADIA ; BAL, PRABJOT S. ; PETRELLA, TERESA ; DENT, REBECCA ; <b>LOPES, GILBERTO</b> . Impact of biomarkers on clinical trial risk in breast cancer. Breast Cancer Research and Treatment<sup><img id='01676806_13' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01676806' /></sup>, v. 136, p. 179-185, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s10549-012-2247-6&issn=01676806&volume=136&issue=&paginaInicial=179&titulo=Impact of biomarkers on clinical trial risk in breast cancer&sequencial=13&nomePeriodico=Breast Cancer Research and Treatment" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>MONTERO, ALBERTO J.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s11912-011-0202-z" target="_blank"></a>MONTERO, ALBERTO J. ; ESCOBAR, MAURICIO ; <b>LOPES, GILBERTO</b> ; GLÜCK, STEFAN ; VOGEL, CHARLES . Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?. CURR ONCOL REP<sup><img id='15233790_14' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15233790' /></sup>, v. 14, p. 1-11, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s11912-011-0202-z&issn=15233790&volume=14&issue=&paginaInicial=1&titulo=Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?&sequencial=14&nomePeriodico=CURR ONCOL REP" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE SOUZA, J. A.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JOP.2012.000612" target="_blank"></a>DE SOUZA, J. A. ; <b>DE LIMA LOPES, G.</b> . What Patients and Providers Should Understand About Economic Evaluations in Oncology. Journal of Oncology Practice<sup><img id='15547477_15' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15547477' /></sup>, v. 8, p. 231-232, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JOP.2012.000612&issn=15547477&volume=8&issue=&paginaInicial=231&titulo=What Patients and Providers Should Understand About Economic Evaluations in Oncology&sequencial=15&nomePeriodico=Journal of Oncology Practice" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>KU, GEOFFREY</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2012</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/S1470-2045(12)70424-2" target="_blank"></a>KU, GEOFFREY ; TAN, IAIN BEEHUAT ; YAU, THOMAS ; BOKU, NARIKAZU ; LAOHAVINIJ, SUDSAWAT ; CHENG, ANN-LII ; KANG, YOON-KOO ; <b>DE LIMA LOPES, GILBERTO</b> . Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncology<sup><img id='14702045_16' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14702045' /></sup>, v. 13, p. e470-e481, 2012. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/S1470-2045(12)70424-2&issn=14702045&volume=13&issue=&paginaInicial=e470&titulo=Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012&sequencial=16&nomePeriodico=Lancet Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>KU, GEOFFREY Y</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1111/j.1743-7563.2010.01345.x" target="_blank"></a>KU, GEOFFREY Y ; <b>DE LIMA LOPES JR, GILBERTO</b> ; CHANG, ALEX Y . Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: A case series. ASIA-PAC J CLIN ONCO<sup><img id='17437555_17' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='17437555' /></sup>, v. 7, p. 174-179, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1111/j.1743-7563.2010.01345.x&issn=17437555&volume=7&issue=&paginaInicial=174&titulo=Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: A case series&sequencial=17&nomePeriodico=ASIA-PAC J CLIN ONCO" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>LIMA LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s00280-011-1588-x" target="_blank"></a><b>LIMA LOPES, GILBERTO</b>; DICKSEY, JENNIFER S. ; PETERS, WILLIAM P. ; PALALAY, MELVIN ; CHANG, ALEX Y. . Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology<sup><img id='03445704_18' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='03445704' /></sup>, v. 68, p. 1067-1073, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s00280-011-1588-x&issn=03445704&volume=68&issue=&paginaInicial=1067&titulo=Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma&sequencial=18&nomePeriodico=Cancer Chemotherapy and Pharmacology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>LOPES JR., GILBERTO DE LIMA</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><b>LOPES JR., GILBERTO DE LIMA</b>; J, Kukuschtca  ; P, Portillo  . Pemetrexed in Asian patients: Experience at the Johns Hopkins Singapore International Medical Centre. SINGAP MED J<sup><img id='00375675_19' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00375675' /></sup>, v. 52, p. 190, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00375675&volume=52&issue=&paginaInicial=190&titulo=Pemetrexed in Asian patients: Experience at the Johns Hopkins Singapore International Medical Centre&sequencial=19&nomePeriodico=SINGAP MED J" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE LIMA LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1186/1471-2407-11-178" target="_blank"></a><b>DE LIMA LOPES, GILBERTO</b>. Societal Costs and Benefits of Treatment with Trastuzumab in Patients with Early HER2neu-Overexpressing Breast Cancer in Singapore. BMC Cancer (Online)<sup><img id='14712407_20' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='14712407' /></sup>, v. 11, p. 178, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1186/1471-2407-11-178&issn=14712407&volume=11&issue=&paginaInicial=178&titulo=Societal Costs and Benefits of Treatment with Trastuzumab in Patients with Early HER2neu-Overexpressing Breast Cancer in Singapore&sequencial=20&nomePeriodico=BMC Cancer (Online)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>KU, GEOFFREY Y.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.lungcan.2011.04.008" target="_blank"></a>KU, GEOFFREY Y. ; HAALAND, BENJAMIN A. ; <b>DE LIMA LOPES, GILBERTO</b> . Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials. Lung Cancer<sup><img id='01695002_21' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01695002' /></sup>, v. 74, p. 469-473, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.lungcan.2011.04.008&issn=01695002&volume=74&issue=&paginaInicial=469&titulo=Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials&sequencial=21&nomePeriodico=Lung Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE SOUZA, J. A.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JOP.2010.000043" target="_blank"></a>DE SOUZA, J. A. ; <b>DE LIMA LOPES, G.</b> . Medicare Reimbursement Changes and the Practice of Oncology: Understanding of the Past Is a Key to the Future. Journal of Oncology Practice<sup><img id='15547477_22' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15547477' /></sup>, v. 7, p. 306-308, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JOP.2010.000043&issn=15547477&volume=7&issue=&paginaInicial=306&titulo=Medicare Reimbursement Changes and the Practice of Oncology: Understanding of the Past Is a Key to the Future&sequencial=22&nomePeriodico=Journal of Oncology Practice" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>KU, GEOFFREY Y</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.2217/thy.10.83" target="_blank"></a>KU, GEOFFREY Y ; <b>LIMA JOPES JR, GILBERTO DE</b> . EML4-ALK in non-small-cell lung cancer: the breathtaking progress from benchtop to Phase III clinical trial. Therapy<sup><img id='1744831X_23' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='1744831X' /></sup>, v. 8, p. 55-61, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.2217/thy.10.83&issn=1744831X&volume=8&issue=&paginaInicial=55&titulo=EML4-ALK in non-small-cell lung cancer: the breathtaking progress from benchtop to Phase III clinical trial&sequencial=23&nomePeriodico=Therapy" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Lopes, G.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2011</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1634/theoncologist.2011-0403" target="_blank"></a><b>Lopes, G.</b>; DENT, R. . Weighed, Measured, and Still Searching: Bevacizumab in the Treatment of Unselected Patients with Advanced Breast Cancer. The Oncologist (Dayton, Ohio)<sup><img id='10837159_24' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='10837159' /></sup>, v. 16, p. 1669-1671, 2011. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1634/theoncologist.2011-0403&issn=10837159&volume=16&issue=&paginaInicial=1669&titulo=Weighed, Measured, and Still Searching: Bevacizumab in the Treatment of Unselected Patients with Advanced Breast Cancer&sequencial=24&nomePeriodico=The Oncologist (Dayton, Ohio)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>BASTOS, BRUNO R.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1097/JTO.0b013e3181ce3e00" target="_blank"></a>BASTOS, BRUNO R. ; HATOUM, GEORGES F. ; WALKER, GAIL R. ; TOLBA, KHALED ; TAKITA, CHRISTIANE ; GOMEZ, JORGE ; SANTOS, EDGARDO S. ; <b>LOPES, GILBERTO</b> ; RAEZ, LUIS E. . Efficacy and Toxicity of Chemoradiotherapy with Carboplatin and Irinotecan Followed by Consolidation Docetaxel for Unresectable Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology<sup><img id='15560864_25' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15560864' /></sup>, v. 5, p. 533-539, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1097/JTO.0b013e3181ce3e00&issn=15560864&volume=5&issue=&paginaInicial=533&titulo=Efficacy and Toxicity of Chemoradiotherapy with Carboplatin and Irinotecan Followed by Consolidation Docetaxel for Unresectable Stage III Non-small Cell Lung Cancer&sequencial=25&nomePeriodico=Journal of Thoracic Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>LOBO, CHRISTOPHER</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s10549-010-1002-0" target="_blank"></a>LOBO, CHRISTOPHER ; <b>LOPES, GILBERTO</b> ; BAEZ, ODALYS ; CASTRELLON, AURELIO ; FERRELL, ANNAPOORNA ; HIGGINS, CONNIE ; HURLEY, ERIN ; HURLEY, JUDITH ; REIS, ISILDINHA ; RICHMAN, STEPHEN ; SEO, PEARL ; SILVA, ORLANDO ; SLINGERLAND, JOYCE ; TUKIA, KELENI ; WELSH, CATHERINE ; GLÜCK, STEFAN . Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer. Breast Cancer Research and Treatment<sup><img id='01676806_26' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01676806' /></sup>, v. 123, p. 427-435, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s10549-010-1002-0&issn=01676806&volume=123&issue=&paginaInicial=427&titulo=Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer&sequencial=26&nomePeriodico=Breast Cancer Research and Treatment" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>KU, GEOFFREY Y.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2010</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.lungcan.2010.08.012" target="_blank"></a>KU, GEOFFREY Y. ; CHOPRA, AKHIL ; <b>LOPES, GILBERTO DE LIMA</b> . Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity. Lung Cancer<sup><img id='01695002_27' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01695002' /></sup>, v. 70, p. 223-225, 2010. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.lungcan.2010.08.012&issn=01695002&volume=70&issue=&paginaInicial=223&titulo=Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity&sequencial=27&nomePeriodico=Lung Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>TAN, KER KAN</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2009</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s11605-008-0757-7" target="_blank"></a>TAN, KER KAN ; <b>LOPES JR., GILBERTO DE LIMA</b> ; SIM, RICHARD . How Uncommon are Isolated Lung Metastases in Colorectal Cancer? A Review from Database of 754 Patients Over 4&nbsp;Years. Journal of Gastrointestinal Surgery<sup><img id='1091255X_28' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='1091255X' /></sup>, v. 13, p. 642-648, 2009. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s11605-008-0757-7&issn=1091255X&volume=13&issue=&paginaInicial=642&titulo=How Uncommon are Isolated Lung Metastases in Colorectal Cancer? A Review from Database of 754 Patients Over 4&nbsp;Years&sequencial=28&nomePeriodico=Journal of Gastrointestinal Surgery" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Lopes, G.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2009</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1377/hlthaff.28.3.922-a" target="_blank"></a><b>Lopes, G.</b>. Rewarding Innovation In Drug Discovery. Health Affairs (Millwood, Va.)<sup><img id='02782715_29' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='02782715' /></sup>, v. 28, p. 922-923, 2009. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1377/hlthaff.28.3.922-a&issn=02782715&volume=28&issue=&paginaInicial=922&titulo=Rewarding Innovation In Drug Discovery&sequencial=29&nomePeriodico=Health Affairs (Millwood, Va.)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE LIMA LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2009</span><b>DE LIMA LOPES, GILBERTO</b>. 'Fin de siècle'--how we got into this financial and economic  crisis and what implications it has for the practice of medicine in Singapore. SINGAP MED J<sup><img id='00375675_30' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00375675' /></sup>, v. 50, p. 648-651, 2009. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=00375675&volume=50&issue=&paginaInicial=648&titulo='Fin de siècle'--how we got into this financial and economic  crisis and what implications it has for the practice of medicine in Singapore&sequencial=30&nomePeriodico=SINGAP MED J" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>31. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE LIMA LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2009</span><b>DE LIMA LOPES, GILBERTO</b>. Perspectives in Lung Cancer--Third Asian-pacific Conference.  11-12 September 2009, Bangkok, Thailand. IDrugs (London)<sup><img id='13697056_31' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='13697056' /></sup>, v. 12, p. 689-691, 2009. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=13697056&volume=12&issue=&paginaInicial=689&titulo=Perspectives in Lung Cancer--Third Asian-pacific Conference.  11-12 September 2009, Bangkok, Thailand&sequencial=31&nomePeriodico=IDrugs (London)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>32. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>SILVA, ORLANDO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2008</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3816/CBC.2008.n.017" target="_blank"></a>SILVA, ORLANDO ; <b>LOPES, GILBERTO</b> ; MORGENZSTERN, DANIEL ; LOBO, CHRISTOPHER ; DOLINY, PHILOMENA ; SANTOS, EDGARDO ; ABDULLAH, SAKHER ; GAUTAM, UMANG ; REIS, ISILDINHA ; WELSH, CATHERINE ; SLINGERLAND, JOYCE ; HURLEY, JUDITH ; GLUCK, STEFAN . A Phase II Trial of Split, Low-Dose Docetaxel and Low-Dose Capecitabine: A Tolerable and Efficacious Regimen in the First-Line Treatment of Patients with HER2/neu-Negative Metastatic Breast Cancer. Clinical Breast Cancer<sup><img id='15268209_32' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15268209' /></sup>, v. 8, p. 162-167, 2008. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3816/CBC.2008.n.017&issn=15268209&volume=8&issue=&paginaInicial=162&titulo=A Phase II Trial of Split, Low-Dose Docetaxel and Low-Dose Capecitabine: A Tolerable and Efficacious Regimen in the First-Line Treatment of Patients with HER2/neu-Negative Metastatic Breast Cancer&sequencial=32&nomePeriodico=Clinical Breast Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>33. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE LIMA LOPES, G.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1200/JCO.2007.12.3760" target="_blank"></a><b>DE LIMA LOPES, G.</b>; GLUCK, S. . Health Economics in the Journal of Clinical Oncology and an Evaluation of the Indirect Costs and Benefits Associated With Adjuvant Trastuzumab. Journal of Clinical Oncology<sup><img id='0732183X_33' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0732183X' /></sup>, v. 25, p. 3382-3383, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1200/JCO.2007.12.3760&issn=0732183X&volume=25&issue=&paginaInicial=3382&titulo=Health Economics in the Journal of Clinical Oncology and an Evaluation of the Indirect Costs and Benefits Associated With Adjuvant Trastuzumab&sequencial=33&nomePeriodico=Journal of Clinical Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>34. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE LIMA LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1002/cncr.22522" target="_blank"></a><b>DE LIMA LOPES, GILBERTO</b>; CHIAPPORI, ALBERTO ; SIMON, GEORGE ; HAURA, ERIC ; SULLIVAN, DAN ; ANTONIA, SCOTT ; LANGEVIN, MICHEL ; LUSH, RICHARD ; ROCHA-LIMA, CAIO MAX . Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors. Cancer (Print)<sup><img id='0008543X_34' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='0008543X' /></sup>, v. 109, p. 1413-1419, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1002/cncr.22522&issn=0008543X&volume=109&issue=&paginaInicial=1413&titulo=Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors&sequencial=34&nomePeriodico=Cancer (Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>35. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>LOBO, CHRISTOPHER</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.biopha.2007.08.008" target="_blank"></a>LOBO, CHRISTOPHER ; <b>LOPES, GILBERTO</b> ; SILVA, ORLANDO ; GLUCK, STEFAN . Paclitaxel albumin-bound particles (abraxane-) in combination with bevacizumab with or without gemcitabine: Early experience at the University of Miami/Braman Family Breast Cancer Institute. Biomedicine & Pharmacotherapy<sup><img id='07533322_35' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='07533322' /></sup>, v. 61, p. 531-533, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.biopha.2007.08.008&issn=07533322&volume=61&issue=&paginaInicial=531&titulo=Paclitaxel albumin-bound particles (abraxane-) in combination with bevacizumab with or without gemcitabine: Early experience at the University of Miami/Braman Family Breast Cancer Institute&sequencial=35&nomePeriodico=Biomedicine & Pharmacotherapy" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>36. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>CHANG, ALEX Y.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3816/CCC.2007.n.033" target="_blank"></a>CHANG, ALEX Y. ; <b>LOPES, GILBERTO</b> ; HSIN, KOO WEN ; LIM, ROBERT ; FONG, FOO KIAN ; WONG, JOHN . Phase II Trial of 5-Fluorouracil/Leucovorin/Gemcitabine/Cisplatin as Second-Line Treatment in Patients with Metastatic or Recurrent Colorectal Carcinoma: A Cancer Therapeutics Research Group Study. Clinical Colorectal Cancer<sup><img id='15330028_36' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15330028' /></sup>, v. 6, p. 646-651, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3816/CCC.2007.n.033&issn=15330028&volume=6&issue=&paginaInicial=646&titulo=Phase II Trial of 5-Fluorouracil/Leucovorin/Gemcitabine/Cisplatin as Second-Line Treatment in Patients with Metastatic or Recurrent Colorectal Carcinoma: A Cancer Therapeutics Research Group Study&sequencial=36&nomePeriodico=Clinical Colorectal Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>37. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3816/CCC.2007.n.032" target="_blank"></a><b>LOPES, GILBERTO</b>; QUESADA, JOSE ; AHN, EUGENE ; FLORES, AUREA ; RIBEIRO, AFONSO ; ROCHA-LIMA, CAIO MAX . Oxaliplatin and Fixed-Rate Infusional Gemcitabine in the Second-Line Treatment of Patients with Metastatic Colon Cancer: Final Results of a Phase II Trial Prematurely Closed as a Result of Poor Accrual. Clinical Colorectal Cancer<sup><img id='15330028_37' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15330028' /></sup>, v. 6, p. 641-645, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3816/CCC.2007.n.032&issn=15330028&volume=6&issue=&paginaInicial=641&titulo=Oxaliplatin and Fixed-Rate Infusional Gemcitabine in the Second-Line Treatment of Patients with Metastatic Colon Cancer: Final Results of a Phase II Trial Prematurely Closed as a Result of Poor Accrual&sequencial=37&nomePeriodico=Clinical Colorectal Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>38. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>DE LIMA LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2007</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1592/phco.27.5.775" target="_blank"></a><b>DE LIMA LOPES, GILBERTO</b>; ROCHA LIMA, CAIO MAX . Emphysematous Cholecystitis in a Patient with Gastrointestinal Stromal Tumor Treated with Sunitinib. Pharmacotherapy (Carlisle, MA.)<sup><img id='02770008_38' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='02770008' /></sup>, v. 27, p. 775-777, 2007. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1592/phco.27.5.775&issn=02770008&volume=27&issue=&paginaInicial=775&titulo=Emphysematous Cholecystitis in a Patient with Gastrointestinal Stromal Tumor Treated with Sunitinib&sequencial=38&nomePeriodico=Pharmacotherapy (Carlisle, MA.)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>39. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>RAEZ, LUIS E.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.lungcan.2006.05.023" target="_blank"></a>RAEZ, LUIS E. ; SANTOS, EDGARDO S. ; <b>LOPES, GILBERTO</b> ; ROSADO, MANUEL F. ; NEGRET, LAWRENCE M. ; ROCHA-LIMA, CAIO ; TOLBA, KALHED ; FARFAN, NANCY ; HAMILTON-NELSON, KARA ; SILVA, ORLANDO ; ROMAN, ELOY . Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC). Lung Cancer<sup><img id='01695002_39' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01695002' /></sup>, v. 53, p. 347-353, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.lungcan.2006.05.023&issn=01695002&volume=53&issue=&paginaInicial=347&titulo=Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC)&sequencial=39&nomePeriodico=Lung Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>40. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>GARCIA, SANTIAGO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1097/01.smj.0000233020.68212.8f" target="_blank"></a>GARCIA, SANTIAGO ; CANONIERO, MARIANA ; <b>LOPES, GILBERTO</b> ; SORIANO, ANDRÉS OMAR . Metamizole Use Among Hispanics in Miami: Report of a Survey Conducted in a Primary Care Setting. Southern Medical Journal (Birmingham, Ala. Print)<sup><img id='00384348_40' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00384348' /></sup>, v. 99, p. 924-926, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1097/01.smj.0000233020.68212.8f&issn=00384348&volume=99&issue=&paginaInicial=924&titulo=Metamizole Use Among Hispanics in Miami: Report of a Survey Conducted in a Primary Care Setting&sequencial=40&nomePeriodico=Southern Medical Journal (Birmingham, Ala. Print)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>41. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1016/j.lungcan.2005.10.008" target="_blank"></a><b>LOPES, GILBERTO</b>; VINCEK, VLADIMIR ; RAEZ, LUIS E. . Pemetrexed-associated urticarial vasculitis. Lung Cancer<sup><img id='01695002_41' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01695002' /></sup>, v. 51, p. 247-249, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1016/j.lungcan.2005.10.008&issn=01695002&volume=51&issue=&paginaInicial=247&titulo=Pemetrexed-associated urticarial vasculitis&sequencial=41&nomePeriodico=Lung Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>42. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.3816/CBC.2006.n.041" target="_blank"></a><b>LOPES, GILBERTO</b>; DECESARE, TERESA ; GHURANI, GISELLE ; VINCEK, VLADIMIR ; JORDA, MERCE ; GLÜCK, STEFAN ; SILVA, ORLANDO . Primary Ectopic Breast Cancer Presenting as a Vulvar Mass. Clinical Breast Cancer<sup><img id='15268209_42' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='15268209' /></sup>, v. 7, p. 278-279, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.3816/CBC.2006.n.041&issn=15268209&volume=7&issue=&paginaInicial=278&titulo=Primary Ectopic Breast Cancer Presenting as a Vulvar Mass&sequencial=42&nomePeriodico=Clinical Breast Cancer" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>43. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>GARCIA, SANTIAGO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2006</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1592/phco.26.3.440" target="_blank"></a>GARCIA, SANTIAGO ; CANIONERO, MARIANA ; <b>LOPES, GILBERTO</b> . Dipyrone-Induced Granulocytopenia: A Case for Awareness. Pharmacotherapy (Carlisle, MA.)<sup><img id='02770008_43' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='02770008' /></sup>, v. 26, p. 440-442, 2006. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1592/phco.26.3.440&issn=02770008&volume=26&issue=&paginaInicial=440&titulo=Dipyrone-Induced Granulocytopenia: A Case for Awareness&sequencial=43&nomePeriodico=Pharmacotherapy (Carlisle, MA.)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>44. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>LOPES, GILBERTO</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2005</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1053/j.seminoncol.2005.04.003" target="_blank"></a><b>LOPES, GILBERTO</b>; ROCHA LIMA, CAIO MAX S. . Docetaxel in the Management of Advanced Pancreatic Cancer. Seminars in Oncology<sup><img id='00937754_44' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='00937754' /></sup>, v. 32, p. 10-23, 2005. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1053/j.seminoncol.2005.04.003&issn=00937754&volume=32&issue=&paginaInicial=10&titulo=Docetaxel in the Management of Advanced Pancreatic Cancer&sequencial=44&nomePeriodico=Seminars in Oncology" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>45. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Escalon, M.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2005</span>Escalon, M. ; <b>DE LIMA LOPES, GILBERTO</b> . T-cell non-Hodgkin s lymphoma: prognostic factors and treatment. The American Journal of Oncology Review<sup><img id='1537453X_45' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='1537453X' /></sup>, v. 4, p. 766-769, 2005. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=1537453X&volume=4&issue=&paginaInicial=766&titulo=T-cell non-Hodgkin s lymphoma: prognostic factors and treatment&sequencial=45&nomePeriodico=The American Journal of Oncology Review" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>46. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>CHIRINOS, JULIO A</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>2004</span><a class="icone-producao icone-doi" href="http://dx.doi.org/10.1007/s10067-003-0816-0" target="_blank"></a>CHIRINOS, JULIO A ; TAMARIZ, LEONARDO J. ; <b>LOPES, GILBERTO</b> ; DEL CARPIO, FREDDY ; ZHANG, XIAOHONG ; MILIKOWSKI, CLARA ; LICHTSTEIN, DANIEL M. . Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clinical Rheumatology (Printed)<sup><img id='07703198_46' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='07703198' /></sup>, v. 23, p. 152-159, 2004. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=10.1007/s10067-003-0816-0&issn=07703198&volume=23&issue=&paginaInicial=152&titulo=Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature&sequencial=46&nomePeriodico=Clinical Rheumatology (Printed)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>47. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Lopes G</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1996</span><b>Lopes G</b>; Gerchman, F. ; Bolognesi, G. ; Osorio, M.V.S. ; Bisol, T. ; Von Eye, G.  . Hipertricose Ciliar Adquirida em SIDA, Uma Revisao. [Hypertricosis of the Eyelashes in AIDS: A Review]. Revista HCPA (UFRGS. Impresso)<sup><img id='01015575_47' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01015575' /></sup>, v. 16, p. 25-27, 1996. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=01015575&volume=16&issue=&paginaInicial=25&titulo=Hipertricose Ciliar Adquirida em SIDA, Uma Revisao. [Hypertricosis of the Eyelashes in AIDS: A Review]&sequencial=47&nomePeriodico=Revista HCPA (UFRGS. Impresso)" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
<div class="artigo-completo">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>48. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><span class='informacao-artigo' data-tipo-ordenacao='importancia'></span><span class='informacao-artigo' data-tipo-ordenacao='autor'>Gerchman, F.</span><span class='informacao-artigo' data-tipo-ordenacao='ano'>1995</span>Gerchman, F. ; <b>LOPES JUNIOR, G. L.</b> ; Bolognesi, G. ; Ferreira, J.  ; Bisol, T. . Hipertricose Ciliar como sinal semiologico da Sindrome da Imunodeficiencia Adquirida. [Hypertricosis of the Eyelashes as a semiologic sign of AIDS]. Revista AMRIGS<sup><img id='01022105_48' src='/buscatextual/images/curriculo/jcr.gif' style ='display: none' class='ajaxJCR' data-issn='01022105' /></sup>, v. 39, p. 246, 1995. <div class="citacoes" cvURI="/buscatextual/servletcitacoes?doi=&issn=01022105&volume=39&issue=&paginaInicial=246&titulo=Hipertricose Ciliar como sinal semiologico da Sindrome da Imunodeficiencia Adquirida. [Hypertricosis of the Eyelashes as a semiologic sign of AIDS]&sequencial=48&nomePeriodico=Revista AMRIGS" tooltip="Citações a partir de 1996" ></div></div>
</div>
<br class="clear">
</div>
</div>
<div class="cita-artigos">
<b><a name="CapitulosLivrosPublicados"></a>Capítulos de livros publicados</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES JR, GILBERTO</b>. Diagnostic procedures. In: Silva O, Raez L. (Org.). Lung cancer: a practical guide. 1ed.: Elsevier, 2008, v. , p. 1-. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES JR, GILBERTO</b>; Raez, L . Adjuvant chemotherapy in non-small cell lung cancer. In: Silva O, Raez L. (Org.). Lung cancer: a practical guide. 1ed.: Elsevier, 2008, v. , p. 3-. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES JR, GILBERTO</b>; ROCHA LIMA, CAIO M. . Cancer de Pancreas. In: Guimaraes J. (Org.). Rotinas em Oncologia. 1ed.: Artes Médicas, 2008, v. , p. 1-. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES JR, GILBERTO</b>; SILVA, ORLANDO . Investigational Agents. In: Silva O, Zurrida S. (Org.). Breast cancer: a practical guide. 1ed.: Elsevier, 2005, v. , p. 1-. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES JR, GILBERTO</b>; SILVA, ORLANDO ; GLUCK, S. . Adjuvant Hormonal Therapy. In: Silva O, Zurrida S. (Org.). Breast cancer: a practical guide. 1ed.: Elsevier, 2005, v. , p. 3-. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES JR, GILBERTO</b>; SILVA, ORLANDO . Benign breast disease. In: Silva O, Zurrida S. (Org.). Breast cancer: a practical guide. 1ed.: Elsevier, 2005, v. , p. 5-. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES JR, GILBERTO</b>; Sprinz, E . Infecções por Herpes Vírus: Simples, Varicela-Zoster, Epstein-Barr, HSV-8. In: Sprinz E, Finkelsztejn A Sprinz E, Finkelsztejn A. (Org.). Rotinas em HIV e AIDS. 1ed.: , 1999, v. , p. 1-. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="TrabalhosPublicadosAnaisCongresso"></a>Resumos publicados em anais de congressos</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">MONTERO, ALBERTO J. ; AVANCHA, KIRAN ; GLUCK, S. ; <b>DE LIMA LOPES, GILBERTO</b> . Cost-effectiveness analysis of eribulin (E) versus treatment of physician s choice (TPC) in patients (pts) with pretreated metastatic breast cancer (MBC). In: 2012 ASCO Annual Meeting, 2012, Chicago. J Clin Oncol, 2012. v. 30. p. e16525. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Chopra, A. ; MONTERO, ALBERTO J. ; AVANCHA, KIRAN ; GLUCK, S. ; <b>DE LIMA LOPES, GILBERTO</b> . Cost-effectiveness evaluation of abiraterone in the treatment of patients with castration-resistant prostate cancer who previously received docetaxel. In: 2012 ASCO Annual Meeting, 2012, Chicago. J Clin Oncol, 2012. v. 30. p. e15107. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">HAALAND, BENJAMIN A. ; Chopra, A. ; <b>DE LIMA LOPES, GILBERTO</b> . Comparative effectiveness of front-line agents in the treatment of metastatic clear cell renal cell carcinoma. In: 2012 ASCO Annual Meeting, 2012. J Clin Oncol, 2012. v. 30. p. e15045. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Falconi, A. ; <b>DE LIMA LOPES, GILBERTO</b> ; PARKER, JAYSON L. . Clinical trial risk reduction in non-small cell lung cancer though the use of biomarkers and receptor-targeted therapies. In: 2012 ASCO Annual Meeting, 2012. J Clin Oncol, 2012. v. 31. p. 8040. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Zeichner, S.B. ; AVANCHA, KIRAN ; <b>DE LIMA LOPES, GILBERTO</b> ; GLUCK, S. ; MONTERO, ALBERTO J. . Cost-effectiveness of everolimus plus exemestane in post-menopausal hormone receptor positive metastatic breast cancer. In: 2012 ASCO Annual Meeting, 2012. J Clin Oncol, 2012. v. 31. p. 6548. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>; CHIEN, REBECCA ; Skrzypczak, S. . Cost-benefit analysis of a 21-gene recurrence score for early stage breast cancer in Singapore.. In: St Gallen Oncology Conference, 2011, St. Gallen. Abstract Book, 2011. p. P215A. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">SANTOS, EDGARDO ; Behshid, K ; Zelnick, L ; <b>DE LIMA LOPES, GILBERTO</b> ; Jorda, M ; Bejarano, P ; Raez, L . Significance of the adhesion molecule CEACAM1 (CD66a) as a prognostic factor for survival in patients with carcinomas of the lung. In: 95th Annual Meeting of the American Association for Cancer Research, 2004, Orlando. Abstract Book, 2004. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Schwartsmann, G ; Sprinz, E ; Stefani, S ; Leone, L ; Loitzenbauer, B ; Bortolini, M ; Kronfeld, M ; <b>DE LIMA LOPES, GILBERTO</b> ; Sander, E ; Mans, D . Clinical and pharmacokinetic study of etoposide given orally three times daily to patients with AIDS-related Kaposi s sarcoma (AIDS-KS). In: 17th International Cancer Congress, 1998, Rio de Janeiro. Proceedings American Society Clinical Oncology, 1998. v. 17. p. 966. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Brondani, A ; Mans, DRA ; Bernard, EA ; <b>DE LIMA LOPES, GILBERTO</b> ; Schwartsmann, G . Inhibition of protein kinase C (PKC) activity by tamoxifen in cultured gliomas cells. In: 87th Annual Meeting of the American Association for Cancer Research., 1996. Abstract Book, 1996. v. 1. p. 2889. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Mans, DRA ; Malcon, C ; <b>DE LIMA LOPES JR, GILBERTO</b> . dose Tamoxifen interferes with Etoposide disposition in the cerebrospinal fluid of gliomas patients and p-glycoprotein-expressing tissues in rats. In: VI Scientific Initiation Meeting at Federal University of Rio Grande do Sul, 1994, Toronto. Abstract Book, 1994. v. 1. p. 1755-1755. </div>
</div>
<br class="clear">
<div class="cita-artigos">
<b><a name="ApresentacoesTrabalho"></a>Apresentações de Trabalho</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">KU, GEOFFREY Y ; HAALAND, BENJAMIN A. ; <b>DE LIMA LOPES, GILBERTO</b> . Cetuximab (C225) in the first-line treatment of advanced colorectal cancer (CRC) patients (Pts) with K-ras wild-type (WT) tumors: Does the choice and schedule of fluoropyrimidine (Fp) matter?. 2012. (Apresentação de Trabalho/Simpósio). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">KU, GEOFFREY Y ; HAALAND, BENJAMIN A. ; <b>DE LIMA LOPES, GILBERTO</b> . Meta-analysis of randomized phase II and phase III trials of gemcitabine with/without S-1 in Asian patients with advanced pancreatic cancer. 2012. (Apresentação de Trabalho/Simpósio). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>; Liau, K. ; Ho, C. . Gefitinib in the adjuvant treatment of hepatocellular carcinoma: A pilot study by the Singapore hepatocellular carcinoma consortium. 2011. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>; FINKELSTEIN, ERIC A. ; DO, YOUNG K. . Cost effectiveness of EGFR mutation testing and gefitinib. Accepted as oral presentation and recipient of Clinician-Investigator Silver award. 2011. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>; HOSEIN, PETER J. ; ROCHA-LIMA, CAIO . Nab-paclitaxel (NP) is active in patients with advanced pancreatic cancer (PC) who have progressed on gemcitabine(G)-based therapy. 2011. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>; Zhang, S. ; CHANG, ALEX Y . Cost-effectiveness assessment of aprepitant in the prevention of chemotherapy-induced nausea and vomiting. 2011. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">MONTERO, ALBERTO J. ; GLUCK, S. ; <b>DE LIMA LOPES, GILBERTO</b> . Cost-effectiveness of bevacizumab in the treatment of advanced breast cancer. 2011. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>; SEGEL, JOEL E. ; Tan, D. ; DO, YOUNG K. ; MOK, TONY ; FINKELSTEIN, ERIC A. . Comparative Clinical and Cost-Effectiveness Evaluation of Gefitinib and Erlotinib in the Treatment of Advanced Non-Small Cell Lung Cancer. 2011. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>; SEGEL, JOEL E. ; Tan, D. ; DO, YOUNG K. ; Novello, S. ; Scagliotti, G. ; MOK, TONY ; FINKELSTEIN, ERIC A. . Epidermal Growth Factor Receptor (EGFR) Mutation Testing and First Line Treatment with Gefitinib is a Dominant Strategy  in the Treatment of Asian and European Patients with Advanced Non-Small Lung Cancer (NSCLC). 2011. (Apresentação de Trabalho/Conferência ou palestra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>; FINKELSTEIN, ERIC A. ; DO, YOUNG K. . Cost effectiveness of EGFR mutation testing and gefitinib. Accepted as oral presentation and recipient of Clinician-Investigator Silver award. 2010. (Apresentação de Trabalho/Outra). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>; CHIEN, REBECCA ; HORNBERGER, JOHN . Cost benefit analysis of a 21-gene recurrence score in Singapore. Accepted as oral presentation and winner of the Young Investigator award, Health Outcomes Research category.. 2010. (Apresentação de Trabalho/Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>; Soh. J. ; Wong, W. ; Tan, D. ; Lim, K. ; FONG, FOO KIAN ; Poon, D. ; Ong, S. ; Mesenas, S. ; CHANG, ALEX Y ; Singapore Gastric Cancer Consortium . A multicenter phase II study of neoadjuvant docetaxel and capecitabine in the treatment of gastric cancer in Singapore. 2009. (Apresentação de Trabalho/Simpósio). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>; Ho, C. ; Liau, K. ; Chung, A. ; Cheow, P. ; CHANG, ALEX Y ; Singapore Gastric Cancer Consortium . Adjuvant gefitinib in hepatocellular carcinoma (HCC): An ongoing pilot study by the Singapore Hepatocellular Carcinoma Consortium. 2009. (Apresentação de Trabalho/Simpósio). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>; Alencar, A. ; Blaya, M. . Gemcitabine and oxaliplatin as second and third line therapy of advanced and metastatic NSCLC: preliminary evidence of activity and improvement in quality of life. 2007. (Apresentação de Trabalho/Comunicação). </div>
</div>
<br class="clear">
<a name="ProducaoTecnica"></a><br class="clear" /><div class="inst_back">
<b>Produção técnica</b>
</div>
<div class="cita-artigos">
<b><a name="TrabalhosTecnicos"></a>Trabalhos técnicos</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for American Journal of Public Health. 2013. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Member of the Editorial Board for South Asian Journal of Cancer. 2013. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Cancer Control: Journal of the Moffitt Cancer Center. 2012. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Breast Cancer: Targets and Therapy. 2012. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Health and Quality of Life Outcomes. 2012. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Member of the Editorial Board for The Journal of Market Access and Health Policy. 2012. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Lung Cancer. 2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Journal of Oncology Practice, 2011 (8 reviews). 2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Onkologie. 2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for British Journal of Cancer. 2011. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for the Journal of Graduate Medical Education. 2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for the BMC Cancer. 2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Value in Health and Value in Health Regional Issues, since 2010 (7 reviews). 2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Singapore Medical Journal, since 2010 (4 reviews). 2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Member of the Editorial Board for The Journal of Thoracic Diseases. 2010. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Clinical Breast Cancer. 2009. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Member of the Editorial Board for The World Journal of Gastrointestinal Surgery. 2009. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Journal of Thoracic Oncology, since 2008, 9 reviews. 2008. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Archives of Gynecology and Obstetrics. 2008. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Member of the Editorial Board for The Open Colorectal Cancer Journal. 2008. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer, ASCO SEP: Medical Oncology Self Evaluation Program, 2007. 2007. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for journal Cancer, since 2007, 3 reviews. 2007. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for journal Clinical Medicine: Oncology, 2007. 2007. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Cancer Chemotherapy and Pharmacology, since 2007, 2 reviews. 2007. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Cancer Informatics. 2007. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for journal Pharmacotherapy, since 2006, 2 reviews. 2006. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for Asia Pacific Journal of Clinical Oncology, since 2006, 9 reviews. 2006. </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5"><b>DE LIMA LOPES, GILBERTO</b>. Invited Reviewer for journal The Breast, since 2005, 8 reviews. 2005. </div>
</div>
<br class="clear">
</div><br class="clear" /></div><br class="clear" /><div class="title-wrapper">
<a name="Eventos">
<h1>Eventos</h1>
</a>
<hr class="separator">
<div class="layout-cell layout-cell-12 data-cell">
<div class="layout-cell layout-cell-12 data-cell">
<a name="ParticipacaoEventos"></a><br class="clear" /><div class="inst_back">
<b>Participação em eventos, congressos, exposições e feiras</b>
</div>
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>1. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Faculty for 2013 World Conference on Lung Cancer.Faculty for 2013 World Conference on Lung Cancer. 2013. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>2. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">2012 ASCO Annual Meeting.Cost-effectiveness analysis of eribulin (E) versus treatment of physician s choice (TPC) in patients (pts) with pretreated metastatic breast cancer (MBC).
							2012. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>3. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Contemporary management of lung cancer. Malaysian Thoracic Society symposium.Contemporary management of lung cancer.
							2012. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>4. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">First-line treatment of non-small cell lung cancer. First International Lung Cancer Symposium.First-line treatment of non-small cell lung cancer.
							2012. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>5. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gastrointestinal Cancers Symposium.Cetuximab (C225) in the first-line treatment of advanced colorectal cancer (CRC) patients (Pts) with K-ras wild-type (WT) tumors: Does the choice and schedule of fluoropyrimidine (Fp) matter?.
							2012. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>6. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Individualized first line treatment of non-small cell lung cancer: making the most  cents . Malaysian Oncological Society symposium.Individualized first line treatment of non-small cell lung cancer: making the most  cents .
							2012. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>7. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Management of patients with EGFR TKI resistant lung cancer. First International Lung Cancer Symposium.Management of patients with EGFR TKI resistant lung cancer.
							2012. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>8. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Presentation and discussion of study on Best of ASCO SE Asia: A randomized, multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab in previously untreated advanced esophagogastric cancer (REAL3)..103. Presentation and discussion of study on Best of ASCO SE Asia: A randomized, multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab in previously untreated advanced esophagogastric cancer (REAL3). 2012. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>9. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Presentation and discussion of study on Best of ASCO SE Asia: Phase III randomized trial of definitive chemoradiotherapy (CRT) with FOLFOX or cisplatin and fluorouracil in esophageal cancer (EC): Final results of the PRODIGE 5/ACCORD 17 trial..102. Presentation and discussion of study on Best of ASCO SE Asia: Phase III randomized trial of definitive chemoradiotherapy (CRT) with FOLFOX or cisplatin and fluorouracil in esophageal cancer (EC): Final results of the PRODIGE 5/ACCORD 17 trial. 2012. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>10. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">American Society of Clinical Oncology Annual Meeting (ASCO).Gefitinib in the adjuvant treatment of hepatocellular carcinoma: A pilot study by the Singapore hepatocellular carcinoma consortium.
							2011. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>11. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Asian Oncology Summit. Winner.Nab-paclitaxel (NP) is active in patients with advanced pancreatic cancer (PC) who have progressed on gemcitabine(G)-based therapy. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>12. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Economic indicators, cost-effectiveness and their importance in the practice of oncology. American Society of Clinical Oncology and Brazilian Society of Clinical Oncology (ASCO/SBOC) joint symposium on pharmacoeconomics at the SBOC Congress.Economic indicators, cost-effectiveness and their importance in the practice of oncology.
							2011. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>13. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">MAASC Meeting 2011.Cost-effectiveness assessment of aprepitant in the prevention of chemotherapy-induced nausea and vomiting.
							2011. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>14. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Moderator, Urologic Cancers Session, Asian Oncology Summit.Moderator, Urologic Cancers Session. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>15. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Moderator: Palliative Care Session. Asian Oncology Summit.Moderator: Palliative Care Session. Asian Oncology Summit. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>16. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">St Gallen Oncology Conference.Cost-benefit analysis of a 21-gene recurrence score for early stage breast cancer in Singapore.. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>17. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">World Lung Cancer Conference.Comparative Clinical and Cost-Effectiveness Evaluation of Gefitinib and Erlotinib in the Treatment of Advanced Non-Small Cell Lung Cancer. 2011. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>18. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">4th International Society of Pharmaconomics and Outcomes Research (ISPOR) meeting.Cost-benefit analysis of a 21-gene recurrence score for early stage breast cancer in Singapore.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>19. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Cancer, moderator for oral presentations, International Society for Pharmaco-economics and Outcomes Research Asian Meeting.Cancer, moderator for oral presentations.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>20. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">First Singapore Health and Biomedical Congress. Cost effectiveness of EGFR mutation testing and gefitinib. Accepted as oral presentation and recipient of Clinician-Investigator Silver award. 2010. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>21. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gastrointestinal cancer symposium. (ASCO GI).A cost-effectiveness assessment of sorafenib in the treatment of hepatocellular carcinoma in Singapore.
							2010. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>22. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Using genomic profiling to select therapy in early breast cancer in Asia. International Society for Pharmacoeconomics and Outcomes Research Asian Meeting.Using genomic profiling to select therapy in early breast cancer in Asia.
							2010. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>23. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">Gastrointestinal Cancer Symposium (ASCO GI).A multicenter phase II study of neoadjuvant docetaxel and capecitabine in the treatment of gastric cancer in Singapore.
							2009. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>24. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">12th World Lung Cancer Conference.Gemcitabine and oxaliplatin as second and third line therapy of advanced and metastatic NSCLC: preliminary evidence of activity and improvement in quality of life. 2007. (Outra). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>25. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">2005 Amgen  oncology fellows and pharmacy residents symposium.Free Circulating Deoxyribonucleic Acid (DNA) in Serum as Measured by Real Time Polymerase Chain Reaction (RT-PCR): A New Prognostic and Predictive Factor in Non-Small Cell Lung Cancer?.
							2005. (Simpósio). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>26. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">95th Annual Meeting of the American Association for Cancer Research.Significance of the adhesion molecule CEACAM1 (CD66a) as a prognostic factor for survival in patients with carcinomas of the lung.
							2004. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>27. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">17th International Cancer Congress. Clinical and pharmacokinetic study of etoposide given orally three times daily to patients with AIDS-related Kaposi s sarcoma (AIDS-KS)h. 1998. (Congresso). </div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>28. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">87th Annual Meeting of the American Association for Cancer Research..Inhibition of protein kinase C (PKC) activity by tamoxifen in cultured gliomas cells.
							1996. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>29. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">86th Annual Meeting. American Association for Cancer Research.dose Tamoxifen interferes with Etoposide disposition in the cerebrospinal fluid of gliomas patients and p-glycoprotein-expressing tissues in rats.
							1995. (Encontro). 
					</div>
</div>
<br class="clear">
<div class="layout-cell layout-cell-1 text-align-right">
<div class="layout-cell-pad-5 text-align-right">
<b>30. </b>
</div>
</div>
<div class="layout-cell layout-cell-11">
<div class="layout-cell-pad-5">VI Scientific Initiation Meeting at Federal University of Rio Grande do Sul.Altered disposition of etoposide (VP-16) by tamoxifen (TMX) in p-glycoprotein (p-gp)- containing tissues in rats.
							1994. (Encontro). 
					</div>
</div>
<br class="clear">
</div>
</div><br class="clear" /></div><br class="clear" /><br class="clear" /><div class="rodape-cv">P&aacute;gina gerada pelo Sistema Curr&iacute;culo Lattes em 19/09/2019 &agrave;s 23:30:06</div><br class="clear" /><div class="control-bar-wrapper"><a href="download.do?metodo=apresentar&amp;idcnpq=2260229603109116" target="_blank" class="button"><span class="mini-ico mini-ico-down"></span>Baixar Currículo</a><a class="button" href="javascript:window.print()"><span class="mini-ico mini-ico-list"></span>Imprimir Curr&iacute;culo</a>
</div><br class="clear" /></div>
</div>
</div>
</div>
</div>
<div class="to-top-bar" id="toTop">
<a href="javascript:void(0)" class="topo-width center">
<div class="id-orgao">
<span>CNPq</span> | Uma ag&ecirc;ncia do Minist&eacute;rio da Ci&ecirc;ncia, Tecnologia e Inova&ccedil;&atilde;o</div>
</a>
</div>
</BODY>
</HTML>
